Symeou Dental Center, a well-established dental clinic based in the heart of Nicosia, has announced the expansion of its ...

NanoViricides, Inc. (NYSE American: NNVC) announced it will present at the BIO International Convention 2025 in Boston on Monday, June 16 at 2:30 p.m ...

"I, like many other advisers, spent many hours after school and on weekends, while students worked on their events," Mitchell's Joan Anderson writes in a column about FCCLA.

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

(“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that its research ...

According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...

In a moment of prestige and international recognition, Dr Shabir Hassan, a leading Kashmir biotechnology researcher and academic from Khalifa University in the United Arab Emirates, was awarded the ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...

PSQ Holdings, Inc. (NYSE: PSQH) ("PublicSquare," or the "Company"), America's leading marketplace and payments ecosystem ...

Terra Innovatum’s SOLO™ Micro-Modular Reactor Offers Safe, Affordable, and Reliable 24/7 Power Without Refueling for 15 Years ...

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...

MODY 5 is a rare genetic diabetes subtype caused by HNF1B mutations or deletions, often presenting with early-onset diabetes and kidney, liver, or pancreatic abnormalities. Accurate genetic diagnosis ...